Miramar Capital’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-146,412
| Closed | -$14.1M | – | 58 |
|
|
2025
Q4 | $14.1M | Sell |
146,412
-1,238
| -0.8% | -$120K | 3.07% | 16 |
|
|
2025
Q3 | $14.1M | Buy |
147,650
+653
| +0.4% | +$60K | 3.12% | 15 |
|
|
2025
Q2 | $12.8M | Buy |
146,997
+903
| +0.6% | +$76.6K | 3.03% | 14 |
|
|
2025
Q1 | $13.1M | Sell |
146,094
-5,423
| -4% | -$485K | 3.12% | 13 |
|
|
2024
Q4 | $12.1M | Sell |
151,517
-650
| -0.4% | -$56.3K | 2.89% | 16 |
|
|
2024
Q3 | $13.7M | Buy |
152,167
+2,163
| +1% | +$182K | 3.2% | 10 |
|
|
2024
Q2 | $11.8M | Buy |
150,004
+265
| +0.2% | +$21.7K | 2.95% | 15 |
|
|
2024
Q1 | $12.3M | Buy |
149,739
+35
| +0% | +$2.99K | 3.1% | 15 |
|
|
2023
Q4 | $12.3M | Sell |
149,704
-4,335
| -3% | -$330K | 3.21% | 15 |
|
|
2023
Q3 | $12.1M | Sell |
154,039
-3,648
| -2% | -$305K | 3.28% | 13 |
|
|
2023
Q2 | $13.9M | Buy |
157,687
+1,005
| +0.6% | +$86.5K | 3.52% | 12 |
|
|
2023
Q1 | $12.6M | Buy |
156,682
+29,315
| +23% | +$2.39M | 3.25% | 11 |
|
|
2022
Q4 | $9.9M | Buy |
127,367
+15,756
| +14% | +$1.28M | 2.59% | 22 |
|
|
2022
Q3 | $8.85M | Buy |
111,611
+2,919
| +3% | +$262K | 2.44% | 25 |
|
|
2022
Q2 | $9.76M | Buy |
108,692
+15,121
| +16% | +$1.53M | 2.76% | 15 |
|
|
2022
Q1 | $10.4M | Buy |
93,571
+24,017
| +35% | +$2.54M | 2.85% | 12 |
|
|
2021
Q4 | $7.2M | Buy |
69,554
+14,308
| +26% | +$1.66M | 2.44% | 23 |
|
|
2021
Q3 | $6.92M | Buy |
55,246
+625
| +1% | +$80.9K | 2.76% | 24 |
|
|
2021
Q2 | $6.99M | Buy |
54,621
+647
| +1% | +$81.2K | 2.82% | 22 |
|
|
2021
Q1 | $6.38M | Sell |
53,974
-211
| -0.4% | -$24.7K | 2.85% | 20 |
|
|
2020
Q4 | $6.4M | Buy |
54,185
+6,027
| +13% | +$663K | 2.85% | 15 |
|
|
2020
Q3 | $5.25M | Buy |
48,158
+669
| +1% | +$67.2K | 3.05% | 20 |
|
|
2020
Q2 | $4.57M | Buy |
47,489
+2,372
| +5% | +$227K | 2.82% | 24 |
|
|
2020
Q1 | $4.07M | Sell |
45,117
-1,236
| -3% | -$131K | 3.71% | 14 |
|
|
2019
Q4 | $5.56M | Buy |
46,353
+43
| +0.1% | +$4.72K | 3.4% | 12 |
|
|
2019
Q3 | $4.94M | Buy |
46,310
+780
| +2% | +$81.4K | 3.33% | 15 |
|
|
2019
Q2 | $4.65M | Buy |
45,530
+6,775
| +17% | +$619K | 3.29% | 13 |
|
|
2019
Q1 | $3.53M | Buy |
38,755
+22,908
| +145% | +$2.05M | 2.7% | 18 |
|
|
2018
Q4 | $1.43M | Buy |
+15,847
| New | +$1.48M | 1.12% | 28 |
|
Other funds holding MDT
VCM
VPM
Miramar Capital's MDT Position: Q1 2026 in Review
Miramar Capital sold out of Medtronic (MDT) in Q1 2026, closing a stake of 146,412 shares — an estimated $14.1M sold.
Miramar Capital first reported a position in MDT in Q4 2018 and held it in 29 quarters. The position peaked at $14.1M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Miramar Capital reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Miramar Capital sold 146,412 Medtronic shares in Q1 2026, an estimated $14.1M.
- Miramar Capital first reported a position in Medtronic in Q4 2018 and held it in 29 quarters.
- Miramar Capital's Medtronic position peaked at $14.1M in Q4 2025.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Miramar Capital's 13F filing for Q1 2026, filed 11 May 2026.